Life Sciences PA presents complimentary virtual events each year thanks to the generosity of our sponsors. Below you will find on demand recordings from a variety of topics including diversity, equity and inclusion, finance operations, legal answers, and more.
LSPA partners with experts at KPMG to provide members a timely and relevant series for financial planning and operations. The topics that were discussed in this session are: Advisory Landscape – the economic landscape means for strategic planning for R&D companies Human Resources: Compensation & Benefits – discrepancy between capabilities and compensation, CFO Hiring and packages Deal Making & Reverse Mergers – the time it takes for deals to happen i.e. state of economy considerations, time it takes to value a company, culture of compensation, etc. Different types of deals, reverse mergers, SPACs (a fad that is fading?)
In this session, various KPMG tax partners and professionals will discuss what companies across the Life Sciences industry are facing with regard to the ERC and other federal and state incentives for the coming year as well as the tax considerations of a remote workforce.
In this session, various KPMG tax partners and professionals will discuss what companies across the Life Sciences industry are facing with regard to recent economic developments as well as industry trends in state, local, and value-added tax considerations.
This edition will focus on audits of financial statements, deferred compensation and 409A compensation, and Pennsylvania state budget considerations and what they mean for the R&D credit pool.
After attending this session, participants should be able to:
After attending this session, participants should be able to:
Survive and Thrive in the Current Fundraising Environment Market distress brings challenges, but also opportunities. In this session, Ballard Spahr experts will discuss what life sciences companies need to know about the legal aspects of fundraising, including Deal terms and how they are changing Prioritizing Programs Licensing IP as an asset.
This episode of LAW was moderated by Ryan Udell featuring Robert Barron, an experienced life science trial lawyer and partner at Ballard Spahr. Ryan and Robert discuss real world guidance related to forum selection, dispute resolution, indemnity and arbitration clauses as well as IP/inventorship disputes, supply orders and obligations and termination provisions.
In our kick-off to the series, this session tackles common challenges in protecting innovation in the life sciences arenas, to successfully protect your business’ objectives. Hear from experienced Ballard Spahr speakers who have decades of experience helping their clients navigate an ever-evolving IP landscape on a range of topics germane to your business.
Licensing Agreements and Partnering
In this episode, learn about the best practices in licensing and partnering agreements. Hear from veteran Ballard Spahr lawyers, who have decades of experience working on these types of transactions in the life sciences industry.
Moderator: Ryan Udell, Partner
For our last LAW session of the year, our moderator Ryan Udell was joined by two of his Ballard Spahr partners, Meredith Dante and Brian Pinheiro, as they discuss top of mind employment issues and incentive compensation structures and strategies to help you continue to navigate the rapidly evolving post-Covid environment.
In this session of Advocacy Abstract, hear experts from Kimbell & Associates and Winning Strategies Washington discuss comprehensive and efficient federal policy information.
Topics for this session included:
Speakers:
Rob Zucker, Partner, Winning Strategies Washington
Charla Penn, Principal, Winning Strategies Washington
John Ray, Senior Director, Government Affairs, Kimbell Associates
This first session of Advocacy Abstract provides an outlook on the first session of the 118th Congress. This discussion led by government relations professionals touches on topics such as: what a Republican-controlled U.S. House means for life sciences innovation and how companies should prepare for implementation of the drug price negotiation provisions in the Inflation Reduction Act, among others.
Panelists:
Michael Merola, Managing Partner, Winning Strategies Washington
John Ray, Senior Director, Government Affairs, Kimbell & Associates
Moderator:
Amy Redl, Senior Director, Federal Government Affairs, Sanofi
Panel Discussion on changing DE&I landscape:
Panel Discussion on changing DE&I landscape:
Panel Discussion
Panel Discussion
Panel Discussion
Panel Discussion
Sponsored by Thermo Fisher Scientific and PPD, experts will present innovative strategies in outsourcing discovery that allows small companies to focus on their core discovery needs and frees them up from both a capital and manpower investment.
In this session, attendees will hear from experts about outsourcing discovery research – evaluating your options.
Speaker: Erik Willems, PhD., Senior Manager Cell Biology, Research and Development, Thermo Fisher Scientific
Session Topic – Discovery: The do’s and don’t’s, experience perspective, and recognition of workarounds that enable the process.
Speakers:
Life Sciences PA, Danforth Advisors and Gallagher present The Art of Fundraising. In this edition, hear from panelists Roberto Cuca and Matt Medeiros as they discuss:
The Art of Fundraising Series – Preparing for the Seed Round
Hear from industry experts on how you should prepare to start looking for seed funding. Topics covered will include:
The Art of Fundraising – Episode 1
Experts from Danforth Advisors will give advice on raising capital for your organization. This will focus on the different stages of fundraising as well as providing real life examples.